Literature DB >> 8529682

Soluble CD23 antigen in Kawasaki disease and other acute febrile illnesses.

T Matsubara1, S Furukawa, T Motohashi, K Okumura, K Yabuta.   

Abstract

Kawasaki disease (KD) is an acute febrile illness of early childhood. Although the epidemiology of KD suggests an infectious agent, the cause still remains unknown. Intense immune activation during the acute disease has been well documented. Quantitative determination of soluble CD23 in serum can serve as an index of macrophage/monocyte or B-cell activation. To further characterize the immunological profile in KD, we investigated whether soluble CD23 levels in serum increase during the acute disease. In addition, we compared soluble CD23 levels in 33 patients with acute KD with levels in ten patients each with measles, rubella, infectious mononucleosis, and scarlet fever to determine if marked elevations in soluble CD23 were unique to acute KD. Patients with KD, rubella and infectious mononucleosis, but not patients with measles or scarlet fever, had increased soluble CD23 levels in serum during the acute stage, as compared to age-matched control subjects (P < 0.01). These data suggest infection with Epstein-Barr virus and rubella and acute KD are all characterized by B-cell and macrophage/monocyte activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8529682     DOI: 10.1007/bf01959791

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  Increased expression of CD23 on peripheral blood B cells and macrophages/monocytes during acute infectious mononucleosis.

Authors:  S Furukawa; T Motohashi; T Matsubara; T Watanabe; T Obara; K Yabuta
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

2.  Decreased expression of CD23 on peripheral blood macrophages/monocytes during acute Kawasaki disease with coronary artery lesions.

Authors:  S Furukawa; T Matsubara; K Okumura; K Yabuta
Journal:  Int Arch Allergy Immunol       Date:  1993       Impact factor: 2.749

3.  Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia.

Authors:  M Sarfati; D Bron; L Lagneaux; C Fonteyn; H Frost; G Delespesse
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

4.  A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan.

Authors:  H Yanagawa; Y Nakamura; M Yashiro; Y Fujita; M Nagai; T Kawasaki; S Aso; Y Imada; I Shigematsu
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

5.  Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus.

Authors:  A Bansal; T Roberts; E M Hay; R Kay; R S Pumphrey; P B Wilson
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

6.  Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases.

Authors:  T Matsumoto; T Miike; K Yamaguchi; M Murakami; T Kawabe; J Yodoi
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

7.  Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus.

Authors:  M al-Janadi; A al-Wabel; S Raziuddin
Journal:  Clin Immunol Immunopathol       Date:  1994-04

8.  Serum measurements of soluble CD23 in HIV infection.

Authors:  A S Bansal; R S Pumphrey; B K Mandal; S H Khoo; P B Wilson
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

9.  Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.

Authors:  D Y Leung; H C Meissner; D R Fulton; D L Murray; B L Kotzin; P M Schlievert
Journal:  Lancet       Date:  1993-12-04       Impact factor: 79.321

10.  Presence of antigenic determinants common to Fc IgE receptors on human macrophages, T and B lymphocytes and IgE-binding factors.

Authors:  M Sarfati; T Nutman; C Fonteyn; G Delespesse
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

View more
  2 in total

1.  Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.

Authors:  J C Burns; C Shimizu; H Shike; J W Newburger; R P Sundel; A L Baker; T Matsubara; Y Ishikawa; V A Brophy; S Cheng; M A Grow; L L Steiner; N Kono; R M Cantor
Journal:  Genes Immun       Date:  2005-08       Impact factor: 2.676

Review 2.  Kawasaki Disease and Allergic Diseases.

Authors:  Po-Yu Huang; Ying-Hsien Huang; Mindy Ming-Huey Guo; Ling-Sai Chang; Ho-Chang Kuo
Journal:  Front Pediatr       Date:  2021-01-07       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.